Fig 1: AMPKα and β subunits are substrates of LUBAC ubiquitination.A Immunoblots of FLAG-AMPKα1/2 IP from HEK293T cells co-transfected with LUBAC (HOIL-1 and HOIP), OTULIN-WT, catalytically inactive OTULIN-C129A (CA), or vector. B, C Immunoblots of M1-linked Ub conjugates purified from HEK293T cells transfected with LUBAC (HOIL-1, SHARPIN, and HOIP-WT or HOIP-C885S (CS)) (B) or LUBAC (HOIL-1 and HOIP) and OTULIN-WT or OTULIN-C129A (CA) (C) using recombinant GST-M1-Trap or GST-M1-SUB. D Immunoblots of in vitro ubiquitination assay (left) of HA-AMPKα1/2 IP from HEK293T cells (right) using recombinant E1, E2, LUBAC (HOIP, HOIL-1, and SHARPIN), and ubiquitin. All blots are representative of three (A, B, D) or two (C) independent experiments.
Fig 2: Proteomics identify LUBAC and OTULIN as interactors of AMPK.A Volcano plot of proteins from MS analysis of Strep-OTULIN affinity-purification (AP) from HEK293T cells versus vector control. Known OTULIN interactors (teal) and AMPK pathway proteins (orange) highlighted. False discovery rate (FDR) < 0.05; Fold-change (FC) cutoff 2.5. B Immunoblots of Strep-OTULIN AP from HEK293T cells transfected with 2xHA-2xStrep-OTULIN or vector. C Immunoblots of Strep-HOIP AP from HEK293T cells co-transfected with V5-HOIL-1, V5-SHARPIN, and either 2xHA-2xStrep-HOIP or vector. Immunoblots of endogenous HOIP (D) or OTULIN (E) immunoprecipitation (IP) from WT, HOIP-KO, and OTULIN-KO U2OS cells. F Top: Schematic representation of HOIP variants, including full-length wild-type (FL-WT), truncated mutants (PUB-UBA, PUB-NZFs, PUB, RBR-LDD), and the catalytically inactive mutant (FL-C885S). Bottom: Immunoblots of HA-tagged HOIP variants AP from HEK293T cells transfected with V5-HOIL-1, V5-SHARPIN, and 2xHA-2xStrep-HOIP or vector. G Left: Immunoblots of Strep-OTULIN AP from HEK293T cells transfected with 2xHA-2xStrep-OTULIN variants or vector. Right: Schematic of OTULIN WT, ΔPBM, Y56A, and ΔN mutants. H Volcano plot of proteins from MS analysis of Strep-AMPKα1 (PRKAA1) AP from HEK293T cells versus vector control. AMPK subunits (PRKAB1/2 and PRKAG1) (orange) and OTULIN and HOIP (RNF31) (blue) are highlighted. FDR < 0.05; FC cutoff 3.7. I Immunoblots of endogenous AMPKα1/2 IP from U2OS WT or AMPKα1/2 double-KO (DKO) cells. J Immunoblots of FLAG-AMPKα1 or α2 IP from HEK293T cells transfected with vector, 2xFLAG-2xStrep-AMPKα1, or α2. All blots are representative of three independent experiments.
Fig 3: Immune cell infiltration landscape and correlation between hub genes and M2 macrophage-mediated immunosuppression in HCC-depression comorbidity. (A) Box plots of immune cell infiltration proportions comparing normal vs tumor, control vs depression cohorts. (B) Representative flow cytometry dot plots for peripheral CD206+M2 macrophages from each treatment group. (C) Correlation heatmap of GLCE/RBCK1/BTN3A3 expression with multiple immune cell subsets. (D) ELISA quantification of immunosuppressive cytokines IL-10 and TGF-β in mouse serum compared with the model group, *p < 0.05 or **p < 0.01. n=3.
Fig 4: Single-cell transcriptomic profiling of BTN3A3, GLCE and RBCK1 in depressive brain tissue. (A) UMAP plots showing cell clustering and cell-type annotation of brain single-cell RNA-seq dataset under depressive status. (B) Dot plot of canonical marker genes for brain cell subset annotation. (C) Feature UMAP plots of BTN3A3, GLCE, and RBCK1 across brain single cells. (D) Dot plot showing average expression and detection percentage of three hub genes in annotated brain cell populations. (E) Violin plots of BTN3A3, GLCE and RBCK1 expression across brain cell types. (F) Heatmap of pathway-activity signatures correlated with hub-gene expression. Red boxes indicate kynurenine metabolism pathways. All analyses were performed on public single-cell RNA-seq dataset.
Fig 5: Single-cell transcriptomic profiling of BTN3A3, GLCE and RBCK1 in human hepatocellular carcinoma. (A) UMAP plots showing cell clustering and cell-type annotation of human HCC single-cell RNA-seq dataset. (B) Dot plot of canonical marker genes for tumor-infiltrating cell subset annotation. (C) Feature UMAP plots of BTN3A3, GLCE, and RBCK1 across tumor single cells. (D) Dot plot showing average expression and detection percentage of three hub genes in annotated cell populations. Red boxes indicate T cells and macrophages. (E) Violin plots of BTN3A3, GLCE and RBCK1 expression across cell types. Red boxes indicate T cells and macrophages. (F) Heatmap of pathway-activity signatures correlated with hub-gene expression. Red boxes indicate tryptophan metabolism and kynurenine metabolism pathways. This analysis was performed on public single-cell RNA-seq dataset.
Supplier Page from Abcam for Anti-RBCK1 antibody [EPR28157-53]